Journal of Genetic Syndromes & Gene Therapy

Journal of Genetic Syndromes & Gene Therapy
Open Access

ISSN: ISSN: 2157-7412

+1-8507546199

Aims and Scope

Journal of Genetic Syndromes & Gene Therapy (JGSGT), is rapidly growing field of research which encompasses the continuous coverage of all biological, clinical trials and medical aspects of potential gene therapies and treatment for the genetic disorders or abnormalities and cancers through the modification of gene expression and also we can actually rewrite our own human nature at its most fundamental level. Its broad focus makes it an excellent resource for researchers to disseminate their cutting-edge findings. With this in mind, we have set up Genetic Syndromes & Gene Therapy to provide the genomic community a useful platform inviting new research in the development of Gene Therapy for Genetic Syndromes.

In today's wired world information is available at the click of the button, curtsey the Internet. Journal of Genetic Syndromes & Gene Therapy- Open Access gives a world wide audience larger than that of any subscription-based journal in Longdom Publishing SL field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Journal of Genetic Syndromes & Gene Therapy- Open Access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, "mash-ups" and other forms of processing and analysis. Journal of Genetic Syndromes & Gene Therapy- Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content.

Longdom Publishing SL is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in Longdom Publishing SL scientific and technical disciplines.

All published articles will be assigned DOI provided by CrossRef. Journal of Genetic Syndromes & Gene Therapy will keep upto date with latest advances in the field and papers published in Journal of Genetic Syndromes & Gene Therapy will reach the readers directly by email for free of cost.

Distributed widely through the Internet.

Archived online in the transactions of the Longdom Publishing SL, which provides the international scientific community with immediate and permanent access to individual papers.

ournal of Genetic Syndromes and Gene Therapy accepts online letters to the editors, brief comments that contributes to the previously published articles or other relevant findings in Longdom Publishing SL field.

Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Journal of Genetic Syndromes and Gene Therapy strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Journal of Genetic Syndromes & Gene Therapy are freely accessible to everyone immediately after publication.

All works published by Longdom Publishing SL are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Journal of Genetic Syndromes & Gene Therapy supports the Bethesda Statement on Open Access Publishing.

he Journal of Genetic Syndromes & Gene Therapy provides reliable information updating online viewers with the modified methods and latest advancements in the field of gene therapy for diverse genetic disorders.

Definition of Open Access Publication

An Open Access Publication is one that meets the following two conditions:

  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.

  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).

As a member of Publisher International linking Association, PILA, Journal of Genetic Syndromes & Gene Therapy (of Longdom Publishing SL ) follows the Creative Commons Attribution License and Scholars Open Access publishing policies.

Note:

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.

Top